Robert Driscoll

Stock Analyst at Wedbush

(0.76)
# 2481
Out of 5,438 analysts
208
Total ratings
Success rate
Average return
Main Sectors:
Top Industries:
40 Stocks
Name Action PT Current % Upside Ratings Updated
REPL Replimune Group
Downgrades: Neutral
19 4
4.98 -19.68% 6 Jul 22, 2025
CBIO Crescent Biopharma
Initiates Coverage On: Outperform
27
12.96 108.33% 1 Jul 14, 2025
KURA Kura Oncology
Reiterates: Outperform
36 36
5.54 549.82% 10 Jun 20, 2025
ZNTL Zentalis Pharma
Reiterates: Neutral
4 4
1.4 185.71% 11 May 15, 2025
HOWL Werewolf Therapeutic...
Maintains: Outperform
8 6
1.18 408.47% 3 May 9, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
67 67
34.71 93.03% 5 Apr 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
15 17
4.18 306.7% 4 Mar 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
57 12
6.58 82.37% 9 Mar 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
32 32
5.91 441.46% 6 Feb 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
52 52
22.84 127.67% 9 Dec 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
28 28
10.1 177.23% 8 Oct 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
16 16
2.29 598.69% 10 Oct 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
30 30
9.17 227.15% 7 Oct 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
25 22
1.28 1618.75% 10 Oct 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
85 51
8.67 488.24% 1 Sep 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
5 5
0.6 733.33% 8 Sep 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
36 36
7.09 407.76% 4 Sep 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
11 11
1.72 539.53% 3 Aug 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
13 13
4.69 177.19% 7 Aug 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
11 13
6.42 102.49% 4 Aug 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
74 74
22.68 226.28% 7 Aug 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
12 12
n/a n/a 4 Aug 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
8 8
3.33 140.24% 3 Aug 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
7 7
1.35 418.52% 8 Jun 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
65
64.97 0.05% 8 May 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
3 8
2.31 246.32% 9 May 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
8 8
n/a n/a 7 May 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
4 1
n/a n/a 4 Aug 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Jun 20, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
3
3.02 -0.66% 3 May 12, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
25 36
36.01 -0.03% 2 Nov 21, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
50 70
23.01 204.22% 4 May 16, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
9 2
n/a n/a 2 Mar 8, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
136 17
n/a n/a 3 Mar 19, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
5 9
n/a n/a 6 Jun 22, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
2 4
3.34 19.76% 4 May 19, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
1500 250
1.42 17505.63% 1 Mar 19, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
17 3
n/a n/a 3 Nov 12, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
30 34
2.23 1424.66% 1 Apr 4, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
120 160
54.99 190.96% 1 Feb 22, 2017